Globus Medical, Inc. (GMED) Misses Q3 EPS by 1c

Globus Medical, Inc. (NYSE: GMED) reported Q3 EPS of $0.18, $0.01 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $94.76 million versus the consensus estimate of $95.32 million.

For earnings history and earnings-related data on Globus Medical, Inc. (GMED) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Abercrombie & Fitch (ANF) Tops Q2 EPS by $2.19, Offers Guidance
• Movado Group (MOV) Tops Q2 EPS by 19c, Beats on Revenue; Offers Guidance
• Cerence repurchases $10M of convertible notes at below-par price